Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy

References

• Caruso S, Cianci S, Vitale SG, et al. Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy. Eur J Contracept Reprod Health Care. 2018;23:24–31.
   PubMed Web of Science ®Google Scholar
• Caruso S, Cianci S, Malandrino C, et al. Quality of sexual life of women using the contraceptive vaginal ring in extended cycles: preliminary report. Eur J Contracept Reprod Health Care. 2014;19:307–314.
   PubMed Web of Science ®Google Scholar
• Saldanha N. Use of short acting reversible contraception in adolescents: the pill, patch, ring and emergency contraception. Curr Probl Pediatr Adolesc Health Care. 2018;48:333–344.
   PubMed Web of Science ®Google Scholar
• De Leo V, Musacchio MC, Cappelli V, et al. Hormonal contraceptives: pharmacology tailored to women’s health. Hum Reprod Update. 2016;22:634–646.
   PubMed Web of Science ®Google Scholar
• Mack N, Crawford TJ, Guise JM, et al. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception. Cochrane Database Syst Rev. 2019;4:CD004317.
   PubMedGoogle Scholar
• Kennedy CE, Yeh PT, Gaffield ME. Contraception values and preferences: protocol and methods for a global systematic review. Contraception 2020;101:69–73.
   PubMed Web of Science ®Google Scholar
• Caruso S, Cianci S, Cariola M, et al. Improvement of low sexual desire due to antiandrogenic combined oral contraceptives after switching to an oral contraceptive containing 17β-estradiol. J Women’s Health (Larchmt). 2017;26:728–734.
   PubMed Web of Science ®Google Scholar
• Caruso S, Agnello C, Intelisano G, et al. Sexual behavior of women taking low-dose oral contraceptive containing 15 μg ethinylestradiol/60 μg gestodene. Contraception 2004;269:237–240.
   Google Scholar
• Black A, Guilbert E, Costescu D, et al. No. 329 – Canadian contraception consensus part 4 of 4 chapter 9: combined hormonal contraception. J Obstet Gynaecol Can. 2017;39:229–268.
   PubMed Web of Science ®Google Scholar
• Kristjánsdóttir J, Sundelin C, Naessen T. Health-related quality of life in young women starting hormonal contraception: a pilot study. Eur J Contracept Reprod Health Care. 2018;23:171–178.
   PubMed Web of Science ®Google Scholar
• Leon-Larios F, Vazquez-Valeo CG, Sanchez-Sanchez A, et al. Health-related quality of life in undergraduate women using any contraceptive. Health Qual Life Outcomes. 2019;17:90.
   PubMedGoogle Scholar
• Lete I, de la Viuda E, Pérez-Campos E, et al. Effect on quality of life of switching to combined oral contraception based on natural estrogen: an observational, multicentre, prospective phase IV study (ZOCAL Study). Eur J Contracept Reprod Health Care. 2016;21:276–284.
   PubMed Web of Science ®Google Scholar
• Singh S, Sedgh G, Hussain R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud Fam Plann. 2010;41:241–250.
   PubMed Web of Science ®Google Scholar
• Schreiber CA, Sober S, Ratcliffe S, et al. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception 2011;84:230–233.
   PubMed Web of Science ®Google Scholar
• Boesen HC, Rørbye C, Nørgaard M, et al. Sexual behavior during the first eight weeks after legal termination of pregnancy. Acta Obstet Gynecol Scand. 2004;83:1189–1192.
   PubMed Web of Science ®Google Scholar
• Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol. 2012;206:37.e1–37.e6.
   PubMed Web of Science ®Google Scholar
• Winner B, Peipert JF, Zhao Q et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998–2007.
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M, Gandek B, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol. 1998;51:1159–1165.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Albani F, Vaccaro P, et al. Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice. Gynecol Endocrinol. 2008;24:214–219.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Rosen R, Leiblum S, et al. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther. 2002;28:317–330.
   PubMed Web of Science ®Google Scholar
• Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Abalos V, Apter D, et al. Global CARE (Contraception: Access, Resources, Education) Group. Targeting factors for change: contraceptive counselling and care of female adolescents. Eur J Contracept Reprod Health Care. 2016;21:417–430.
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Kopp HK. Post abortion contraception. Women’s Health (Lond). 2015;11:779–784.
   PubMed Web of Science ®Google Scholar
• Hubacher D, Spector H, Monteith C, et al. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction. Contraception 2018;97:524–532.
   PubMed Web of Science ®Google Scholar
• Hognert H, Kopp Kallner H, Cameron S, et al. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion – a randomized controlled equivalence trial. Hum Reprod. 2016;31:2484–2490.
   PubMed Web of Science ®Google Scholar
• Sothornwit J, Werawatakul Y, Kaewrudee S, et al. Immediate versus delayed postpartum insertion of contraceptive implant for contraception. Cochrane Database Syst Rev. 2017;4:CD011913.
   PubMedGoogle Scholar
• Di Carlo C, Sansone A, De Rosa N, et al. Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study. Gynecol Endocrinol. 2014;30:53–56.
   PubMed Web of Science ®Google Scholar
• Chapa HO, Ramirez A, Dawson D. Etonogestrel contraceptive implant-associated secondary anorgasmia. Contraception 2017;96:254–256.
   PubMed Web of Science ®Google Scholar
• Barros Pereira I, Carvalho RM, Graça LM. Intra-abortion contraception with etonogestrel subdermal implant. Eur J Obstet Gynecol Reprod Biol. 2015;185:33–35.
   PubMed Web of Science ®Google Scholar
• Peterson AM, Brown A, Savage A, et al. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users. Eur J Contracept Reprod Health Care. 2019;24:475–479.
   PubMed Web of Science ®Google Scholar
• Guida M, Farris M, Aquino CI, et al. Nexplanon subdermal implant: assessment of sexual profile, metabolism, and bleeding in a cohort of Italian women. Biomed Res Int. 2019;2019:3726957.
   PubMed Web of Science ®Google Scholar
• Sansone A, De Rosa N, Giampaolino P, et al. Effects of etonogestrel implant on quality of life, sexual function, and pelvic pain in women suffering from endometriosis: results from a multicenter, prospective, observational study. Arch Gynecol Obstet. 2018;298:731–736.
   PubMed Web of Science ®Google Scholar
• Reed S, Do Minh T, Lange JA, et al. Real world data on Nexplanon procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA). Contraception 2019;100:31–36.
   PubMed Web of Science ®Google Scholar
• Committee on Gynecologic Practice Long-Acting Reversible Contraception Working Group. Committee opinion no. 642: increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol. 2015;126:e44–e48.
   PubMed Web of Science ®Google Scholar
• Hubacher D, Spector H, Monteith C, et al. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial. Am J Obstet Gynecol. 2017;216:101–109.
   PubMed Web of Science ®Google Scholar
• Curtis KM, Peipert JF. Long-acting reversible contraception. N Engl J Med. 2017;376:461–468.
   PubMed Web of Science ®Google Scholar
• Birgisson NE, Zhao Q, Secura GM, et al. Preventing unintended pregnancy: the Contraceptive CHOICE Project in review. J Women’s Health (Larchmt). 2015;24:349–353.
   PubMed Web of Science ®Google Scholar
• Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med. 2014;371:1316–1323.
   PubMed Web of Science ®Google Scholar